Otsuka – we contribute to better health
Otsuka is a medical device and pharmaceutical company that develops innovative products within the therapeutic fields of cardiovascular, gastrointestinal and central nervous system disorders.
Otsuka Pharmaceutical Co., Ltd. (OPC) is on of the largest pharmaceutical companies in Japan, and one of 25 largest globally. Otsuka has been operational in the Nordic and Baltic regions as of 2001.
The aims of the organisation in Europe are to be the leading conern within our specialist areas, and to be known for out creative attitude and unique, personal customer service. Our people are at the heart of our company and together we are dedicated to delivering innovative solutions for the recovery and maintenance of better health.
Otsuka Pharma Scandinavia AB has been marketing Adacolumn®, an unique treatment for inflammatory bowel disease. From February 2008, we have launched a new treatment for Intermittent claudication for the Swedish market. On September 1st 2009, we have launched the first vasopressin receptor antagonist for oral usage in Nordic market.
